Company Filing History:
Years Active: 2019
Title: Nagamasa Asami: Innovator in Glycosaminoglycan Sulfation
Introduction
Nagamasa Asami is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the sulfation of glycosaminoglycans. His innovative methods have the potential to impact various applications in medicine and biotechnology.
Latest Patents
Asami holds a patent for a "Method for sulfating glycosaminoglycan." The objective of this invention is to provide a method for sulfating a glycosaminoglycan in a solution of a non-organic solvent. The sulfation reaction is performed with a sulfating agent in a strongly basic solution, with a preferred pH of 11.5 or higher. This method allows for the production of glycosaminoglycans with heparin-like anticoagulant activity from N-acetylheparosan through a one-pot procedure. The resulting sulfated glycosaminoglycan is expected to have a unique disaccharide composition, making it a novel and useful material.
Career Highlights
Nagamasa Asami is associated with Seikagaku Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to glycosaminoglycan sulfation, which could lead to new therapeutic materials.
Collaborations
Asami has collaborated with notable colleagues, including Toshikazu Minamisawa and Hiroshi Fujita. Their combined expertise contributes to the advancement of research in the field of glycosaminoglycans.
Conclusion
Nagamasa Asami's contributions to the sulfation of glycosaminoglycans represent a significant advancement in biochemistry. His innovative methods and collaborations continue to pave the way for new applications in medicine and biotechnology.